145 related articles for article (PubMed ID: 35477273)
1. DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2-COX-2-TP Axis and NLRP3 Inflammasome Activation.
Valencia I; Vallejo S; Dongil P; Romero A; San Hipólito-Luengo Á; Shamoon L; Posada M; García-Olmo D; Carraro R; Erusalimsky JD; Romacho T; Peiró C; Sánchez-Ferrer CF
Hypertension; 2022 Jul; 79(7):1361-1373. PubMed ID: 35477273
[TBL] [Abstract][Full Text] [Related]
2. Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release.
Romacho T; Vallejo S; Villalobos LA; Wronkowitz N; Indrakusuma I; Sell H; Eckel J; Sánchez-Ferrer CF; Peiró C
J Hypertens; 2016 May; 34(5):869-76. PubMed ID: 26895560
[TBL] [Abstract][Full Text] [Related]
3. Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2.
Wronkowitz N; Görgens SW; Romacho T; Villalobos LA; Sánchez-Ferrer CF; Peiró C; Sell H; Eckel J
Biochim Biophys Acta; 2014 Sep; 1842(9):1613-21. PubMed ID: 24928308
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
[TBL] [Abstract][Full Text] [Related]
5. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
Chen Y; Wang L; Pitzer AL; Li X; Li PL; Zhang Y
J Mol Med (Berl); 2016 Dec; 94(12):1335-1347. PubMed ID: 27783111
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway.
Chen Z; Yu J; Fu M; Dong R; Yang Y; Luo J; Hu S; Li W; Xu X; Tu L
Biochem Pharmacol; 2020 Jul; 177():113951. PubMed ID: 32251672
[TBL] [Abstract][Full Text] [Related]
7. Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.
Zhang Y; Li X; Pitzer AL; Chen Y; Wang L; Li PL
Antioxid Redox Signal; 2015 May; 22(13):1084-96. PubMed ID: 25739025
[TBL] [Abstract][Full Text] [Related]
8. Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.
Romacho T; Valencia I; Ramos-González M; Vallejo S; López-Esteban M; Lorenzo O; Cannata P; Romero A; San Hipólito-Luengo A; Gómez-Cerezo JF; Peiró C; Sánchez-Ferrer CF
Sci Rep; 2020 Mar; 10(1):5386. PubMed ID: 32214150
[TBL] [Abstract][Full Text] [Related]
9. Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1.
Chen Y; Pitzer AL; Li X; Li PL; Wang L; Zhang Y
J Cell Mol Med; 2015 Dec; 19(12):2715-27. PubMed ID: 26293846
[TBL] [Abstract][Full Text] [Related]
10. Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance.
Ahmed RH; Huri HZ; Muniandy S; Al-Hamodi Z; Al-Absi B; Alsalahi A; Razif MF
Clin Biochem; 2017 Sep; 50(13-14):746-749. PubMed ID: 28288852
[TBL] [Abstract][Full Text] [Related]
11. Soluble dipeptidyl peptidase-4 induces epithelial-mesenchymal transition through tumor growth factor-β receptor.
Huang CW; Lee SY; Du CX; Ku HC
Pharmacol Rep; 2023 Aug; 75(4):1005-1016. PubMed ID: 37233949
[TBL] [Abstract][Full Text] [Related]
12. Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation.
Shamoon L; Espitia-Corredor JA; Dongil P; Menéndez-Ribes M; Romero A; Valencia I; Díaz-Araya G; Sánchez-Ferrer CF; Peiró C
Biochem Pharmacol; 2022 Jul; 201():115078. PubMed ID: 35551917
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.
Baggio LL; Varin EM; Koehler JA; Cao X; Lokhnygina Y; Stevens SR; Holman RR; Drucker DJ
Nat Commun; 2020 Jul; 11(1):3766. PubMed ID: 32724076
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation.
Zhuang T; Liu J; Chen X; Zhang L; Pi J; Sun H; Li L; Bauer R; Wang H; Yu Z; Zhang Q; Tomlinson B; Chan P; Zheng X; Morrisey E; Liu Z; Reilly M; Zhang Y
Circ Res; 2019 Aug; 125(6):590-605. PubMed ID: 31318658
[TBL] [Abstract][Full Text] [Related]
15. A Thromboxane A
Eckenstaler R; Ripperger A; Hauke M; Petermann M; Hemkemeyer SA; Schwedhelm E; Ergün S; Frye M; Werz O; Koeberle A; Braun H; Benndorf RA
Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):444-461. PubMed ID: 35236104
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation.
Wang L; Chen Y; Li X; Zhang Y; Gulbins E; Zhang Y
Oncotarget; 2016 Nov; 7(45):73229-73241. PubMed ID: 27689324
[TBL] [Abstract][Full Text] [Related]
17. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
[TBL] [Abstract][Full Text] [Related]
18. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction.
Xing JH; Li R; Gao YQ; Wang MY; Liu YZ; Hong J; Dong JZ; Gu HP; Li L
Life Sci; 2019 Dec; 239():116882. PubMed ID: 31705915
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome links vascular senescence to diabetic vascular lesions.
Tai GJ; Yu QQ; Li JP; Wei W; Ji XM; Zheng RF; Li XX; Wei L; Xu M
Pharmacol Res; 2022 Apr; 178():106143. PubMed ID: 35219871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
